Nasus Pharma Ltd. (NSRX) Put/Call Volume History

Put/call volume ratio compares the number of put options traded to call options traded. Extreme readings can signal shifts in market sentiment relative to recent norms.

Nasus Pharma Ltd. (NSRX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $26.0M, listed on AMEX, employing roughly 2 people, carrying a beta of 3.89 to the broader market. Nasus Pharma is a clinical-stage specialty pharmaceutical company focused primarily on the development of intranasal drugs to treat emergency medical conditions such as severe allergies, anaphylaxis, and opioid overdose. Led by Dan Teleman, public since 2025-08-13.

Put/call volume history tracks trading activity and sentiment over time. No recent options activity for NSRX as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options volume is reported and how to read the data →